Skip Navigation


Nucleic Acids Research Advance Access first published online on October 23, 2009
This version published online on November 9, 2009

Nucleic Acids Research, doi:10.1093/nar/gkp817
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (10132K) Freely available
Right arrow Screen PDF (1392K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
gkp817v2    most recent
gkp817v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Baranello, L.
Right arrow Articles by Capranico, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baranello, L.
Right arrow Articles by Capranico, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Molecular Biology

DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1{alpha} gene locus

Laura Baranello1, Davide Bertozzi1, Maria Vittoria Fogli1, Yves Pommier2 and Giovanni Capranico1,*

1"G. Moruzzi" Department of Biochemistry, University of Bologna, 40126 Bologna, Italy and 2Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, MD, USA

*To whom correspondence should be addressed. Tel: +39 51 2094282; Fax: +39 51 2094283; Email: giovanni.capranico{at}unibo.it

Received July 1, 2009. Revised September 14, 2009. Accepted September 15, 2009.

Top1 inhibition by camptothecin (CPT) perturbs RNA polymerase II (Pol II) density at promoters and along transcribed genes suggesting an involvement of Top1 in Pol II pausing. Here, we demonstrate that Top1 inhibition favors Pol II escape from a promoter-proximal pausing site of the human HIF-1{alpha} gene in living cells. Interestingly, alternative splicing at exon 11 was markedly altered in nascent HIF-1{alpha} mRNAs, and chromatin structure was also affected with enhanced histone acetylation and reduced nucleosome density in a manner dependent on cdk activity. Moreover, CPT increases transcription of a novel long RNA (5'aHIF1{alpha}), antisense to human HIF-1{alpha} mRNA, and a known antisense RNA at the 3'-end of the gene, while decreasing mRNA levels under normoxic and hypoxic conditions. The effects require Top1, but are independent from Top1-induced replicative DNA damage. Chromatin RNA immunoprecipitation results showed that CPT can activate antisense transcription mediated by cyclin-dependent kinase (cdk) activity. Thus, Top1 inhibition can trigger a transcriptional stress, involving antisense transcription and increased chromatin accessibility, which is dependent on cdk activity and deregulated Pol II pausing. A changed balance of antisense transcripts and mRNAs may then lead to altered regulation of HIF-1{alpha} activity in human cancer cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.